X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com/news-release/2024/04/24/2868978/18362/en/Amarin-Applauds-HealthyWomen-s-Citizen-s-Petition-Urging-FDA-To-Take-Further-Action-On-Fenofibrate-Prescribing-in-Patients-at-Risk-of-Cardiovascular-Event.html
https://www.newswise.com/coronavirus/after-showing-early-potential-cholesterol-medication-fenofibrate-fails-to-cut-severe-symptoms-or-death-in-covid-19-patients/?article_id=781859
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216798
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212562
https://www.expresspharma.in/lupin-launches-authorised-generic-version-of-antara-in-us/
https://www.lupin.com/lupin-launches-authorized-generic-version-of-antara-in-the-united-states/
https://www.news-medical.net/news/20210823/Lipid-lowering-drug-TriCor-dramatically-cuts-treatment-time-for-severe-COVID-19-patients.aspx
https://www.moneycontrol.com/news/trends/health-trends/drug-used-to-reduce-blood-fats-may-cut-sars-cov-2-infection-by-70-study-7287411.html
https://www.labmanager.com/news/new-drug-formulation-method-may-lead-to-smaller-pills-26033
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208476
https://www.pharmaceutical-technology.com/news/study-fenofibrate-covid-19/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213864
https://www.fiercepharma.com/marketing/amarin-launches-cv-risks-awareness-campaign-cautions-outdated-drugs-and-non-fda
https://www.moneycontrol.com/news/business/alembic-pharma-gets-final-usfda-nod-for-fenofibrate-tablets-4848811.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210476
https://www.moneycontrol.com/news/business/alembic-pharma-gets-usfda-nod-for-cholesterol-lowering-drug-4329341.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207564
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209660
https://www.raps.org/news-and-articles/news-articles/2019/1/new-formulations-can-delay-generic-drug-entry-stu?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%201%20February
https://www.reuters.com/article/us-abbvie-settlement/abbott-abbvie-settle-tricor-marketing-case-for-25-million-idUSKCN1N02N2
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-3-2018-1538550050.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210705
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211080
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210606
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210138
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210782
https://www.tga.gov.au/prescription-medicines-registration-new-generic-medicines-and-biosimilar-medicines
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209951
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207805
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200884
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharmas-cholesterol-drug-gets-us-fda-nod/articleshow/58680103.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208705
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205566
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207378
https://www.pharma-excipients.ch/2017/03/03/preparation-of-200-mg-feno-brate-hard-capsule-with-high-dissolution-pro-le-with-microparticle-entrapped-micelles-technology/
https://globenewswire.com/news-release/2017/01/03/902962/0/en/CymaBay-Announces-Exclusive-Licensing-Agreement-with-Kowa-Pharmaceuticals-America-Inc-for-the-Development-and-Commercialization-of-Arhalofenate-in-the-United-States.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208709
https://www.pharmacompass.com/pdf/news/hetero-labs-generic-fenofibrate-approved-in-usa-to-treat-hypercholesterolemia-1468667502.pdf
https://www.pharmacompass.com/pdf/news/mylans-generic-fenofibrate-approved-in-us-for-hyperlipidemia-1467005622.pdf
http://www.prnewswire.com/news-releases/ani-pharmaceuticals-announces-launch-of-50mg-and-150mg-fenofibrate-capsules-in-ani-label-300264537.html
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-final-usfda-nod-for-cholesterol-drug/articleshow/52142446.cms
https://www.pharmacompass.com/pdf/news/aurobindos-generic-fenofibrate-approved-in-us-to-reduce-cholesterol-levels-1462882804.pdf
http://www.fiercepharma.com/pharma/fda-pulls-approvals-on-abbvie-s-ex-blockbuster-heart-meds
http://www.pharma-excipients.ch/2016/03/26/injection-molding-as-a-one-step-process-for-the-direct-production-of-pharmaceutical-dosage-forms-from-primary-powders/
http://www.prnewswire.com/news-releases/ani-pharmaceuticals-acquires-exclusive-rights-to-distribute-three-generic-drug-products-from-h2-pharma-for-10-million-300212311.html
http://www.prnewswire.com/news-releases/pozen-announces-effectiveness-of-aralez-registration-statement-on-form-s-4-and-provides-update-on-key-milestones-for-2016-300197149.html
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0163-2016&w=11112015&lang=eng
Market Place
Share 
